PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28601951-6	2018	MPTP administration also suppressed DJ-1 expression and SOD and CAT activities in the ST, which were restored by acupuncture stimulation at GB34.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0-4	catalase	Mus musculus	64-67	
31028778-8	2019	MPTP administration caused oxidative stress as evidenced by decreased activities of superoxide dismutase and catalase, a depletion of reduced glutathione, and a concomitant rise in malondialdehyde.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0-4	catalase	Mus musculus	109-117	
30433834-7	2019	RESULTS: Pretreatment of NGN significantly reversed the toxic effects of MPTP by reducing LPO levels and increasing the activities of glutathione reductase and catalase along with improved behavioural performance.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	73-77	catalase	Mus musculus	160-168	
20925384-3	2010	MPTP treatment significantly depleted striatal glutathione content, reduced the activity of glutathione peroxidase (GPX), superoxide dismutase (SOD), and catalase, increased malondialdehyde and reactive oxygen species levels, and elevated interleukin-6, nitrite, and tumor necrosis factor-alpha production as well as enhanced inducible nitric oxide synthase (iNOS) activity in the striatum (P < 0.05).	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0-4	catalase	Mus musculus	154-162	
26118717-4	2015	We found that subacute administration of MPTP enhanced lipid and protein oxidation and reduced expression of endogenous antioxidant enzymes (such as superoxide dismutase and catalase) in the striatum.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	41-45	catalase	Mus musculus	174-182	
25944473-4	2015	Further, the levels of TBARS and enzymatic antioxidants such as SOD and catalase, MAO-B activities were enhanced by MPTP treatment.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	116-120	catalase	Mus musculus	72-80	
17574387-5	2007	RESULTS: The MPTP treatment significantly depleted striatal glutathione content, reduced the activity of glutathione peroxidase (GPX), superoxide dismutase (SOD), and catalase, increased malondialdehyde level, and elevated interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) levels in striatum (P < 0.05).	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	13-17	catalase	Mus musculus	167-175	
20157396-2	2008	MPTP treatment increased the activities of total superoxide dismutase, catalase and glutathione peroxidase and the levels of malondialdehyde and carbonyls in the brain compared to control mouse brain.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0-4	catalase	Mus musculus	71-79	
17415533-2	2007	A significant alteration in behavior, increased levels of thiobarbituric acid reactive substance (TBARS), and increased activities of superoxide dismutase (SOD) and catalase (CAT) were noticed in this region of brain in MPTP-treated mice.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	220-224	catalase	Mus musculus	165-173	
17415533-2	2007	A significant alteration in behavior, increased levels of thiobarbituric acid reactive substance (TBARS), and increased activities of superoxide dismutase (SOD) and catalase (CAT) were noticed in this region of brain in MPTP-treated mice.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	220-224	catalase	Mus musculus	175-178	
16910344-3	2006	MPTP treatment caused a significant depletion in GSH and increased the specific activity of SOD, CAT and lipid peroxidation in both ST and MB on the 3rd and 7th day.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0-4	catalase	Mus musculus	97-100	
10899927-2	2000	MPTP treatment increased activities of total superoxide dismutase, catalase, and glutathione peroxidase and levels of malondialdehyde and carbonyls in the basal ganglia, diencephalon plus midbrain of brain compared with control mouse brain.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	0-4	catalase	Mus musculus	67-75	
9657530-7	1998	An MPTP-induced increase in the activity of catalase and superoxide dismutase in substantia nigra on the seventh day was reduced by bromocriptine pretreatment.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	3-7	catalase	Mus musculus	44-52